$Digital Brands Group (DBGI.US)$
Let's push this!

$Lixte Biotechnology (LIXT.US)$
3.7M live volume

My brother @Trytosaveabit will be there for you.

@Jaguar8 Thank you so much 🙏

$PSQ Holdings (PSQH.US)$ PublicSquare Launches New Payments Platform, Secures $5.35M Investment to Drive Growth and Streamline Operations, Aiming for $1B in GMV by Holiday Season
Benzinga· 2 mins ago

$Iterum Therapeutics (ITRM.US)$
Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
Iterum Therapeutics (Nasdaq: ITRM) announces a conference call on October 28, 2024, at 8:30 a.m. EDT to discuss the FDA approval of ORLYNVAH™ (Oral Sulopenem). This groundbreaking treatment for uncomplicated urinary tract infections (uUTIs) marks two significant milestones: it's the first oral penem a...